Cell and Gene Therapy Preclinical Development
Solutions From a Trusted and Experienced Partner

Transform your development by leveraging over 20 years of experience in advanced therapies. Read the case study to see how end-to-end support including CMC refinement with GLP, GMP and GCP testing moved this biologic to the clinic. Find out more about our cell and gene therapy clinical development solutions.

End-to-end support included CMC refinement with GLP, GMP and GCP testing to move this product to the clinic. A complex trial network involved 25 referral sites and a multi-study approach. The impact: advancement of a therapy with the potential to significantly improve the quality-of-life for people living with a rare retinal disease.
If you would like to find out more about how our team at Covance can help in your therapeutic’s development across pre-clinical, clinical and post-approval phases, get in touch by filling out the form below: 
By entering your email address above, you agree to receive marketing communications from Covance Inc. You may withdraw your consent at any time.
We will handle your contact details in line with our Privacy Policy. If you prefer not to receive marketing emails from Covance, you can opt-out of all marketing communications or customize your preferences here

Check out our new

Covance respects your privacy.
Manage your subscriptions.
© Copyright 2020 Covance Inc. All rights reserved.